Project Grant R01AI187725
Award Date
11/15/24
Completion Date
10/31/29
Dollars Obligated
$501K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Chapel Hill, NC 27599, USA
Similar Awards
This federal Project Grant award of $350,000 from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), aims to develop polymer-derived biomaterials for messenger RNA (mRNA) delivery to induce antigen-specific immune tolerance. The award supports research to evaluate diverse nanocarrier formulations encapsulating antigens and mRNAs encoding tolerogenic proteins, investigate the biodistribution and...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under CFDA 93.855 (Allergy and Infectious Diseases Research) provides $586,250.00 to the University of Massachusetts Medical School (UMass Medical) to conduct research on the generation and regulation of TFH13 cells that drive pathogenic IgE in allergic disease. The primary objectives of this 5-year research project are to: 1) determine the role of non-conventional antigen presenting cells...
The federal Project Grant award R21AI182549, in the amount of $246,623.00, was issued by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant supports research to investigate the molecular control of tolerogenic dendritic cell function, which plays a key role in immune homeostasis and tolerance. The research aims to pinpoint the specific dendritic cell subset responsible for maintaining peripheral...
This federal Project Grant award of $521,030.00 from the National Institute of Allergy and Infectious Diseases (NIAID) under CFDA 93.855 Allergy and Infectious Diseases Research program supports research by the University of North Carolina at Chapel Hill (UNC-CH) to investigate the interplay between regulatory and stochastic mechanisms underlying phenotypic heterogeneity in Clostridioides difficile, a major cause of antibiotic-associated disease. The 5-year project aims to define how phase...
This $233,250 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), will fund research to develop a novel platform for gene therapy targeting the human microbiome. The University of North Carolina at Chapel Hill will work to engineer self-recirculating, non-replicating bacteriophages as vectors for precise genetic modifications of specific commensal bacteria within complex microbial...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $231,131 to Duquesne University to develop and evaluate an injectable 3D-clustered human fibroblastic reticular cell (FRC) formulation for expanding regulatory T cells (Tregs). The goal is to leverage FRC-mediated tolerance to prevent allograft rejection in transplant recipients, an alternative to the current...
This federal Project Grant award of $160,000 from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to develop engineered cytokine therapies that can specifically target lipid-laden macrophages. The goal is to locally suppress inflammation in atherosclerosis, a chronic inflammatory disease. The key objectives of the project are to: 1) elucidate the molecular mechanisms by which the...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) provides $379,609 to the University of Pittsburgh to investigate how the immune system, specifically B cells, establishes tolerance to commensal microbes. The research aims to define the mechanisms by which a model commensal antigen induces B cell tolerance, determine the conditions that perturb this tolerance, and examine how...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $210,867 to Drexel University to conduct research on developing tolerogenic dendritic cells (TolDCs) as a cell-based therapy to induce immune tolerance in kidney transplant recipients. The key innovation is the use of "push/pull particle" TolDCs that contain microparticles loaded with a synergistic...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $612,975.00 to the University of Pittsburgh to conduct research aimed at achieving long-term organ transplant acceptance without the need for maintenance immunosuppression. The key goals are to develop a translational model that combines T-cell costimulation blockade with inhibition of monocyte allorecognition via...